Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022)

CompletedOBSERVATIONAL
Enrollment

8,790

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Perennial Allergic RhinitisSeasonal Allergic Rhinitis
All Listed Sponsors
lead

ALK-Abelló A/S

INDUSTRY

NCT01549340 - Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022) | Biotech Hunter | Biotech Hunter